Number of items: 12.
B
Baksh, M. F.
ORCID: https://orcid.org/0000-0003-3107-8815, Böhning, D. and Lerdsuwansri, R.
(2011)
An extension of an over-dispersion test for count data.
Computational Statistics & Data Analysis, 55 (1).
pp. 466-474.
ISSN 0167-9473
doi: https://doi.org/10.1016/j.csda.2010.05.015
Burn, R., Underwood, F. and Blanc, J.
(2011)
Global trends and factors associated with the illegal killing of elephants: a hierarchical bayesian analysis of carcass encounter data.
PLoS ONE, 6 (9).
e24165.
ISSN 1932-6203
doi: https://doi.org/10.1371/journal.pone.0024165
C
Chataway, J., Nicholas, R., Todd, S.
ORCID: https://orcid.org/0000-0002-9981-923X, Miller, D. H., Parsons, N., Valdes-Marquez, E., Stallard, N. and Friede, T.
(2011)
A novel adaptive design strategy increases the efficiency of clinical trials in secondary progressive multiple sclerosis.
Multiple Sclerosis Journal, 17 (1).
pp. 81-88.
ISSN 1477-0970
doi: https://doi.org/10.1177/1352458510382129
D
Didelot, X., Everitt, R. G., Johansen, A. M. and Lawson, D. J.
(2011)
Likelihood-free estimation of model evidence.
Bayesian Analysis, 6 (1).
pp. 49-76.
ISSN 1931-6690
doi: https://doi.org/10.1214/11-BA602
F
Friede, T., Parsons, N., Stallard, N., Todd, S.
ORCID: https://orcid.org/0000-0002-9981-923X, Valdes Marquez, E., Chataway, J. and Nicholas, R.
(2011)
Designing a seamless phase II/III clinical trial using early outcomes for treatment selection: an application in multiple sclerosis.
Statistics in Medicine, 30 (13).
pp. 1528-1540.
ISSN 1097-0258
doi: https://doi.org/10.1002/sim.4202
J
James, G., Zhou, Y. and Miller, S.
(2011)
Modeling data with structural and temporal correlation using lower level and higher level multilevel models.
Pharmaceutical Statistics, 10 (5).
pp. 395-406.
ISSN 1539-1612
doi: https://doi.org/10.1002/pst.479
M
Matcham, J., Julious, S., Pyke, S., O'Kelly, M., Todd, S.
ORCID: https://orcid.org/0000-0002-9981-923X, Seldrup, J. and Day, S.
(2011)
Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry-sponsored clinical trials.
Pharmaceutical Statistics, 10 (1).
pp. 70-73.
ISSN 1539-1612
doi: https://doi.org/10.1002/pst.417
N
Neuman, B. W., Kiss, G., Kunding, A. H., Bhella, D., Baksh, M. F.
ORCID: https://orcid.org/0000-0003-3107-8815, Connelly, S., Droese, B., Klaus, J. P., Makino, S., Sawicki, S. G., Siddell, S. G., Stamou, D. G., Wilson, I. A., Kuhn, P. and Buchmeier, M. J.
(2011)
A structural analysis of M protein in coronavirus assembly and morphology.
Journal of Structural Biology, 174 (1).
pp. 11-22.
ISSN 1047-8477
doi: https://doi.org/10.1016/j.jsb.2010.11.021
O
O'Kelly, M., Julious, S. A., Pyke, S., Day, S., Todd, S.
ORCID: https://orcid.org/0000-0002-9981-923X, Seldrup, J. and Matcham, J.
(2011)
Making available information from studies sponsored by the pharmaceutical industry: some current practices.
Pharmaceutical Statistics, 10 (1).
pp. 60-69.
ISSN 1539-1612
doi: https://doi.org/10.1002/pst.430
P
Pyke, S., Julious, S. A., Day, S., O'Kelly, M., Todd, S.
ORCID: https://orcid.org/0000-0002-9981-923X, Matcham, J. and Seldrup, J.
(2011)
The potential for bias in reporting of industry-sponsored clinical trials.
Pharmaceutical Statistics, 10 (1).
pp. 74-79.
ISSN 1539-1612
doi: https://doi.org/10.1002/pst.429
S
Stallard, N. and Todd, S.
ORCID: https://orcid.org/0000-0002-9981-923X
(2011)
Seamless phase II/III designs.
Statistical Methods in Medical Research, 20 (6).
pp. 623-634.
ISSN 0962-2802
doi: https://doi.org/10.1177/0962280210379035
Z
Zhou, Y.
(2011)
Randomized dose-finding studies: how many dose levels should be used?
Clinical Investigation, 1 (8).
pp. 1061-1063.
ISSN 2041-6792
doi: https://doi.org/10.4155/cli.11.81
This list was generated on Fri Aug 16 06:04:58 2024 UTC.